|
Report Date : |
26.08.2014 |
IDENTIFICATION DETAILS
|
Name : |
EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION |
|
|
|
|
Registered Office : |
5~6F, No.77, Sec.2, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
07.09.1972 |
|
|
|
|
Com. Reg. No.: |
15458455 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacturing and sales of chemical products |
|
|
|
|
No. of Employees |
1,055 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 01, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
Taiwan |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
TAIWAN ECONOMIC OVERVIEW
Taiwan has a dynamic capitalist economy with gradually decreasing government guidance of investment and foreign trade. Exports, led by electronics, machinery, and petrochemicals have provided the primary impetus for economic development. This heavy dependence on exports exposes the economy to fluctuations in world demand. Taiwan's diplomatic isolation, low birth rate, and rapidly aging population are other major long-term challenges. Free trade agreements have proliferated in East Asia over the past several years, and following the landmark Economic Cooperation Framework Agreement (ECFA) signed with China in June 2010, Taiwan in July 2013 signed a free trade deal with New Zealand—Taipei’s first-ever with a country with which it does not maintain diplomatic relations—and in November inked a trade pact with Singapore. Negotiations continue on follow-on components of ECFA regarding trade in goods and a dispute resolution mechanism; a trade in services agreement is under review in the legislature. Taiwan's Total Fertility rate of just over one child per woman is among the lowest in the world, raising the prospect of future labor shortages, falling domestic demand, and declining tax revenues. Taiwan's population is aging quickly, with the number of people over 65 accounting for 11.2% of the island's total population as of 2012. The island runs a large overall trade surplus largely because of its surplus with China, and its foreign reserves are the world's sixth largest, behind China, Japan, Saudi Arabia, Russia, and Switzerland. In 2006 China overtook the US to become Taiwan's second-largest source of imports after Japan. China is also the island's number one destination for foreign direct investment. Taiwan since 2009 has gradually loosened rules governing Chinese investment on the island, and has also secured greater market access for its investors in the mainland. In August 2012, Taiwan Central Bank signed a memorandum of understanding on cross-Strait currency settlement with its Chinese counterpart. The MOU allows for the direct settlement of Chinese RMB and the New Taiwan dollar across the Strait, which could help develop Taiwan into a local RMB hub. Closer economic links with the mainland bring greater opportunities for the Taiwan economy, but also poses new challenges as the island becomes more economically dependent on China while political differences remain unresolved.
|
Source
: CIA |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
5~6F, No.77, Sec.2, Tun Hua South Road, Taipei, Taiwan, Republic of China |
|
Supplied Address: |
|
|
Telephone Number: |
+886-2-2706-6006 |
|
Fax Number: |
|
|
E-mail: |
Notes: The exact name and address are as above.
Subject was incorporated on 1972-9-7 with registered number 15458455 as Joint Stock Company in Taiwan.
Subject listed on Taiwan Stock Exchange on 1988-12-27.
|
Name |
Subscription Shares |
|
Jianxin Chen |
5,796,000 |
|
Dingchuan Chen |
73,500,000 |
|
Weiwang Chen |
5,396,737 |
|
Jianming Chen |
2,447,074 |
|
Degang Zhou |
164,056 |
|
Dingji Chen |
15,326,957 |
|
Yonglong Li |
2,128,992 |
|
Wenyuan Gan |
2,549,536 |
The information above is that of subject’s major shareholders.
Related Companies
|
1 |
|
|
Name: |
Everlight (Suzhou) Advanced Chemicals Ltd. |
|
Address: |
No.33, Pingsheng Road, Suzhou Industrial Park, Jiangsu Province, China |
|
Tel: |
+86-512-6287-1980 |
|
Fax: |
+86-512-6287-1217 |
|
2 |
|
|
Name: |
Ethical International Trading & Warehousing (Shanghai) Co., Ltd |
|
Address: |
Rm.1101, No.2067, West Yan-an Road, Super Ocean Finance Center, Shanghai, China |
|
Tel: |
+86-21-6219-6954 |
|
Fax: |
+86-21-6219-1276 |
|
3 |
|
|
Name: |
Guangzhou Ethical Trading Co., Ltd |
|
Address: |
Room 409,Regal Business Center,No.574-578,TianHe North Road, Guangzhou, China |
|
Tel: |
+86-20-3849-7030 |
|
Fax: |
+86-20-3849-7031 |
|
4 |
|
|
Name: |
Qingdao Ethical Trading Co., Ltd |
|
Address: |
Room 1601, No.29, Shandong Road, Galaxy Building, Qingdao, China |
|
Tel: |
+86-532-8501-6051 |
|
Fax: |
+86-532-8501-6063 |
|
5 |
|
|
Name: |
Guangzhou Mingguang Trade Co., Ltd. |
|
Address: |
Rm.409, Dijing Business Center, 574-578 Tianhe North Rd., Tianhe, Guangzhou, Guangdong, China |
|
Tel: |
+86-20-3849-7030 |
|
6 |
|
|
Name: |
Everlight (Hong Kong) Limited |
|
Address: |
Room 1704, 17F, No.223, Hing Fong Road, Tower 2, Metroplaza, Kwai Chung, N. T. Hong Kong |
|
Registered Number: |
363430 |
|
Date of Registration: |
1992-6-23 |
|
Tel: |
+852-2619-1095 |
|
Fax: |
+852-2619-1031 |
|
7 |
|
|
Name: |
Elite Foreign Trading Inc. |
|
Address: |
Mersin Serbest Bolgesi, Mersin,Turkey |
|
Tel: |
+90-324-237-7789 |
|
Fax: |
+90-324-237-0246 |
|
8 |
|
|
Name: |
Everlight USA, Inc. |
|
Address: |
10507 Southern Loop Blvd., Pineville, NC 28134, U.S.A. |
|
Tel: |
+1-704-588-1004 |
|
Fax: |
+1-704-588-0051 |
|
9 |
|
|
Name: |
Everlight Europe B.V. |
|
Address: |
Rivium Boulevard 112b, 2909 LK Capelle aan den Ijssel, The Netherlands |
|
Tel: |
+31-10-238-0099 |
|
Fax: |
+31-10-238-0090 |
Factory
|
1 |
|
|
Name: |
Everlight Chemical Industrial Corporation 1st Factory |
|
Address: |
No.271, Zhongshan North Road, Neihai Village, Dayuan Township, Taoyuan County, Taiwan, R.O.C. |
|
Date of Foundation: |
1978-6-26 |
|
Date of Registration: |
1980-9-24 |
|
Factory Registration Number: |
99622357 |
|
Factory Manager: |
Jianxin Chen |
|
Status: |
In Production |
|
Date of Last Annual Return: |
2009-9-2 |
|
Major Products: |
192 coating, dye, pigment 089 other food 199 other chemical products |
|
Tel |
+886-3-386-8081 |
|
2 |
|
|
Name: |
Everlight Chemical Industrial Corporation 2nd Factory |
|
Address: |
No.12, Gongye 3rd Road, Shulin Village, Guanyin Township, Taoyuan County, Taiwan, R.O.C. |
|
Date of Foundation: |
1991-4-22 |
|
Date of Registration: |
1991-5-24 |
|
Factory Registration Number: |
99622051 |
|
Factory Manager: |
Jianxin Chen |
|
Status: |
In Production |
|
Date of Last Annual Return: |
2009-7-2 |
|
Major Products: |
181 other chemical materials 192 coating, dye, pigment 199 other chemical products 200 medicine and medical chemical products |
|
3 |
|
|
Name: |
Everlight Chemical Industrial Corporation 3rd Factory |
|
Address: |
No. 935 &937, Chenggong Road, Shulin Village, Guanyin Township, Taoyuan County, Taiwan, R.O.C. |
|
Date of Foundation: |
1992-4-24 |
|
Date of Registration: |
1995-4-17 |
|
Factory Registration Number: |
99622352 |
|
Factory Manager: |
Jianxin Chen |
|
Status: |
In Production |
|
Date of Last Annual Return: |
2009-7-3 |
|
Major Products: |
199 other chemical products 269 other electronic components 181 chemical materials 193 cleaning supplies 194 cosmetic |
|
Tel |
+886-3-483-7682 |
|
3 |
|
|
Name |
Everlight Chemical Industrial Corporation 4th Factory (Under construction) |
|
Address |
No.399, Daze N Road, Taoyuan Science Park, Guanyin Township, Taoyuan County, Taiwan (R.O.C.) |
|
Tel |
+886-3-473-5221 |
Core Management
Directors
|
1 |
|
|
Name |
Jianxin Chen |
|
Position |
Board Chairman |
|
2 |
|
|
Name |
Dingchuan Chen |
|
Position |
Director |
|
3 |
|
|
Name |
Weiwang Chen |
|
Position |
Director/Manager |
|
Date of Appointment |
2001-1-1 |
|
4 |
|
|
Name |
Jianming Chen |
|
Position |
Director |
|
5 |
|
|
Name |
Degang Zhou |
|
Position |
Director |
|
6 |
|
|
Name |
Xiujun Wang |
|
Position |
Independent Director |
|
7 |
|
|
Name |
Yingzheng Hong |
|
Position |
Independent Director |
|
8 |
|
|
Name |
Dingji Chen |
|
Position |
Supervisor |
|
9 |
|
|
Name |
Yonglong Li |
|
Position |
Supervisor |
|
10 |
|
|
Name |
Wenyuan Gan |
|
Position |
Supervisor |
Personnel Structure
|
Total Employees |
About 1,055 Employees (Taiwan) About 1,500 Employees (Global) |
Offices & Factories
|
|
Headquarters |
|
Add |
5~6F, No.77, Sec.2, Tun Hua South Road, Taipei, Taiwan, Republic of China |
Production Information
Subject is a manufacturer of chemical products and etc.
It is introduced that subject has factories in the mainland of China and Taiwan for production.
It is introduced that subject has obtained ISO 9001, ISO 14001, OHSAS 18001, TS16949 and etc certifications.
Purchase Information
The registered activities of subject:
|
Business Code |
Details |
|
C802200 |
Manufacturing of coating, paint, dye and pigment |
|
C802120 |
Manufacturing of industrial additive |
|
C802990 |
Manufacturing of other chemicals |
|
C802041 |
Manufacturing of western medicine |
|
C802060 |
Manufacturing of animal medicine |
|
C802100 |
Manufacturing of cosmetic |
|
C801990 |
Manufacturing of other chemical materials |
|
CA04010 |
Surface treatment |
|
C801010 |
Basic chemical industry |
|
F401010 |
International trade business |
|
C199990 |
Manufacturing of other unclassified food |
|
C802110 |
Manufacturing of cosmetic colorant |
|
F108051 |
Sale of cosmetic colorant |
|
ZZ99999 |
Besides licensed business, all other business items those are not banned or restricted. |
Subject purchases its raw materials and etc both at home and abroad.
It is introduced that subject purchases its raw materials mainly in domestic market, and imports some facilities from America and Europe.
The subject is mainly engaged in sales of chemical products, etc.
It is introduced that subject’s selling territory includes Asia, Europe, America, and etc.
It is introduced that subject’s major customers are textiles industry, printing industry, electronic industry, chemical industry, pharmaceutical industry and etc.
Major Products
|
Type |
Product |
|
Liquid Dyes, Printing Inks, Disk Dyes, Paper Dyes, Metal Surface Colorants, Timber Dyes, Edible Pigments |
|
|
Specialty Chemicals |
Benzophenone Light Stabilizers, Benzotriazole Light Stabilizers and Cosmetic Raw Materials |
|
Medical Chemicals |
Drug Raw Materials, Medical Intermediates |
|
Electronic Chemicals |
Photoresists, Polish Slurries |
|
Nanometer Materials |
Sol-Gels, UV-Curable Hybrids |
Major Sales Volume
|
Type |
Sales Volume of 2013 |
|
Colorant Chemical |
22,142 tons |
|
Specialty Chemicals |
3,309 tons |
|
Medical Chemicals |
29,570 grams (prostaglandin) 1,586 kilograms (others) |
|
Electronic Chemicals |
136,232 gallons (photoresist) 9,618 tons (others) |
|
Nanometer Materials |
5 tons |
Import and export right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Domestic Purchase
|
Product |
Terms |
Proportion |
|
Raw materials and etc |
Cash, T/T, etc |
100% |
Foreign Purchase
|
Product |
Terms |
Proportion |
|
Facilities and etc |
L/C, T/T, etc |
100% |
Sales
Domestic Markets
|
Product |
Terms |
Proportion |
|
Chemical products and etc |
Cash, T/T, etc |
100% |
Export
|
Product |
Terms |
Proportion |
|
Chemical products and etc |
L/C, T/T, etc |
100% |
Unit: NTD/000
|
|
2012-12-31 |
2011-12-31 |
|
Assets |
|
|
|
Current Assets |
|
|
|
Cash and cash equivalents |
440,077.00 |
244,241.00 |
|
Financial assets measured at fair value through profit or loss - current |
70,118.00 |
120,188.00 |
|
Notes receivable - net |
104,186.00 |
90,493.00 |
|
Accounts receivable - net |
642,228.00 |
624,596.00 |
|
Accounts receivable - related parties - net |
453,385.00 |
357,257.00 |
|
Other financial assets - current |
24,471.00 |
24,573.00 |
|
Inventories |
1,695,013.00 |
1,768,133.00 |
|
Other current assets |
86,123.00 |
76,871.00 |
|
Current assets |
3,515,601.00 |
3,306,352.00 |
|
Funds and Investments |
|
|
|
Available-for-sale financial assets - non current |
835,950.00 |
283,176.00 |
|
Financial assets carried at cost - non current |
16,800.00 |
0.00 |
|
Equity investments under equity method |
1,906,028.00 |
2,267,068.00 |
|
Investments |
1,906,028.00 |
2,267,068.00 |
|
Other financial assets - non current |
2,777.00 |
4,935.00 |
|
Funds and long-term investments |
2,761,555.00 |
2,555,179.00 |
|
Fixed Assets |
|
|
|
Cost |
|
|
|
Land |
922,453.00 |
922,453.00 |
|
Buildings and structures |
2,079,636.00 |
2,028,072.00 |
|
Machinery and equipment |
4,963,418.00 |
4,832,985.00 |
|
Office equipment |
203,439.00 |
195,122.00 |
|
Other facilities |
162,876.00 |
158,527.00 |
|
Revaluation increment |
0.00 |
0.00 |
|
Cost and revaluation increment |
8,331,822.00 |
8,137,159.00 |
|
Accumulated depreciation |
-5,955,102.00 |
-5,761,928.00 |
|
Accumulated impairment - fixed assets |
-20,084.00 |
-20,084.00 |
|
Construction in process and prepayment for equipments |
290,161.00 |
121,588.00 |
|
Fixed assets |
2,646,797.00 |
2,476,735.00 |
|
Intangible Assets |
|
|
|
OtherAssets |
|
|
|
Other assets - other |
26.00 |
71.00 |
|
Other assets |
26.00 |
71.00 |
|
Assets |
8,923,979.00 |
8,338,337.00 |
|
Liabilities and Stockholders' Equity |
|
|
|
Liabilities |
|
|
|
Current Liabilities |
|
|
|
Short-term borrowings |
596,285.00 |
571,760.00 |
|
Financial liabilities measured at fair value through profit or loss - current |
0.00 |
1,213.00 |
|
Notes payable |
192,425.00 |
174,302.00 |
|
Accounts payable |
289,578.00 |
230,018.00 |
|
Income tax payable |
56,851.00 |
48,875.00 |
|
Accrued expenses |
298,646.00 |
257,025.00 |
|
Other payables |
35,763.00 |
9,691.00 |
|
Other current liabilities |
58,625.00 |
51,368.00 |
|
Current liabilities |
1,528,173.00 |
1,344,252.00 |
|
Long term Liabilities |
|
|
|
Long-term borrowings |
700,000.00 |
700,000.00 |
|
Long-term liabilities |
700,000.00 |
700,000.00 |
|
Reserves |
|
|
|
Other Liabilities |
|
|
|
Pension reserve / accrued pension liability |
164,229.00 |
124,141.00 |
|
Deferred income tax liabilities |
31,013.00 |
33,275.00 |
|
Other liabilities - other |
32,078.00 |
32,078.00 |
|
Other liabilities |
227,320.00 |
189,494.00 |
|
Liabilities |
2,455,493.00 |
2,233,746.00 |
|
Stockholders' Equity |
|
|
|
Capital |
|
|
|
Common stock |
4,506,371.00 |
4,291,782.00 |
|
Advance receipts for common stock |
0.00 |
0.00 |
|
Capital Surplus |
|
|
|
Capital surplus - additional paid-in capital |
462,559.00 |
462,559.00 |
|
Capital surplus - treasury stock transactions |
10,999.00 |
10,999.00 |
|
Capital surplus - long-term equity investments |
64,835.00 |
94,459.00 |
|
Capital surplus |
538,393.00 |
568,017.00 |
|
Retained Earnings |
|
|
|
Legal reserve |
691,499.00 |
645,448.00 |
|
Special reserve |
24,700.00 |
24,700.00 |
|
Unappropriated retained earnings |
581,176.00 |
553,984.00 |
|
Retained earnings |
1,297,375.00 |
1,224,132.00 |
|
Stockholders' Equity and Other adjustment |
|
|
|
Cumulative translation adjustments |
88,914.00 |
130,445.00 |
|
Net loss not recognized as pension cost |
-170,088.00 |
-119,449.00 |
|
Unrealized gains (losses) on financial instruments |
205,894.00 |
7,285.00 |
|
Unrealized Revaluation Increment |
1,627.00 |
2,379.00 |
|
Equity adjustments |
126,347.00 |
20,660.00 |
|
Stockholders - equity |
6,468,486.00 (USD 214,106,886.60) |
6,104,591.00 (USD 202,061,962.10) |
|
Number of treasury stock acquired by the company and subsidiaries (unit: share) |
0.00 |
0.00 |
|
|
0.00 |
0.00 |
(As of 2014.6, 1 NTD = 0.0331 USD)
Unit: NTD/000
|
|
2012 |
2011 |
|
Sales |
6,109,077.00 (USD 202,210,448.70) |
5,450,001.00 (USD 180,395,033.10) |
|
Sales returns |
14,219.00 |
10,673.00 |
|
Sales discounts and allowances |
1,970.00 |
2,754.00 |
|
Sales |
6,092,888.00 |
5,436,574.00 |
|
Operating income |
6,092,888.00 |
5,436,574.00 |
|
Cost of sales |
4,839,406.00 |
4,433,084.00 |
|
Operating costs |
4,839,406.00 |
4,433,084.00 |
|
Gross profit (loss) from operations |
1,253,482.00 |
1,003,490.00 |
|
Unrealized gains on intercompany transactions |
11,302.00 |
0.00 |
|
Realized gains on intercompany transactions |
0.00 |
12,610.00 |
|
Selling expense |
425,288.00 |
371,932.00 |
|
General and administrative expenses |
169,099.00 |
154,607.00 |
|
Research and development expenses |
271,804.00 |
257,392.00 |
|
Operating expenses |
866,191.00 |
783,931.00 |
|
Operating income (loss) |
375,989.00 |
232,169.00 |
|
Non-Operating Income |
|
|
|
Interest income |
1,071.00 |
970.00 |
|
Income from long-term equity investments under the equity method |
0.00 |
43,973.00 |
|
Dividends |
22,618.00 |
18,001.00 |
|
Investment income |
22,618.00 |
61,974.00 |
|
Gains on disposal of fixed assets |
1,548.00 |
1,319.00 |
|
Gains on sale of investments |
139,489.00 |
171,748.00 |
|
Foreign exchange gains |
0.00 |
13,306.00 |
|
Revaluation gain on financial assets |
646.00 |
354.00 |
|
Revaluation gain on financial liabilities |
1,213.00 |
3,507.00 |
|
Miscellaneous income |
46,408.00 |
50,977.00 |
|
Non-operating revenues and gains |
212,993.00 |
304,155.00 |
|
Non-Operating Expenses |
|
|
|
Interest expense |
20,686.00 |
23,785.00 |
|
Losses from long-term equity investments under the equity method |
4,566.00 |
0.00 |
|
Investment loss |
4,566.00 |
0.00 |
|
Loss on disposal of fixed assets |
5,136.00 |
4,901.00 |
|
Foreign exchange losses |
72.00 |
0.00 |
|
Miscellaneous disbursements |
1,350.00 |
626.00 |
|
Non-operating expenses and losses |
31,810.00 |
29,312.00 |
|
Income from continuing operations before income tax |
557,172.00 |
507,012.00 |
|
Income tax expense (benefit) |
54,751.00 |
46,505.00 |
|
Income from continuing operations |
502,421.00 |
460,507.00 |
|
Net income (loss) |
502,421.00 |
460,507.00 |
|
Primary Earnings per Share |
|
|
|
Primary earnings per share |
1.11 |
1.02 |
|
Diluted earnings per share |
|
|
|
Diluted earnings per share |
1.11 |
1.02 |
(As of 2014.6, 1 NTD = 0.0331 USD)
Unit: NTD/000
|
|
2012 |
2011 |
|
Cash Flows from Operating Activities - Indirect Method |
|
|
|
Net Income (Loss) |
502,421.00 |
460,507.00 |
|
Adjustments to Reconcile Net Income to Net Cash Provided by (Used in) Operating Activities |
|
|
|
Depreciation Expense |
265,108.00 |
250,770.00 |
|
Amortization Expense |
45.00 |
1,794.00 |
|
Provision (Reversal of Provision) for Bad Debts Losses |
2,512.00 |
-2,324.00 |
|
Loss (Gain) on Decline (Recovery) in Market Value, Scrap and Obsolescence of Inventories |
108.00 |
-3,808.00 |
|
Investment Loss (Income) Recognized under Equity Method |
4,566.00 |
-43,973.00 |
|
Cash Dividends Received from Investments Accounted for under Equity Method |
71,501.00 |
56,722.00 |
|
Loss (Gain) on Disposal of Property, Plant and Equipment |
3,588.00 |
3,582.00 |
|
Loss (Gain) on Disposal of Investments |
-139,489.00 |
-171,748.00 |
|
Unrealized Revaluation Loss (Gain) on Financial Assets and Liabilities |
-1,859.00 |
-3,861.00 |
|
Unrealized Gain (Loss) on Intercompany Transactions |
11,302.00 |
0.00 |
|
Realized Loss (Gain) on Intercompany Transactions |
0.00 |
-12,610.00 |
|
Loss (Gain) on Deferred Income Tax |
-2,694.00 |
-697.00 |
|
Changes in Operating Assets and Liabilities |
|
|
|
Decrease (Increase) in Notes Receivable |
-14,013.00 |
37,951.00 |
|
Decrease (Increase) in Accounts Receivable |
-17,623.00 |
-44,304.00 |
|
Decrease (Increase) in Accounts Receivable - Related Parties |
-96,128.00 |
8,150.00 |
|
Decrease (Increase) in Inventories |
73,012.00 |
39,454.00 |
|
Decrease (Increase) in Other Current Assets |
-8,820.00 |
-3,352.00 |
|
Decrease (Increase) in Other Financial Assets |
9,651.00 |
-2,325.00 |
|
Increase (Decrease) in Notes Payable |
18,123.00 |
-465.00 |
|
Increase (Decrease) in Accounts Payable |
59,560.00 |
-52,592.00 |
|
Increase (Decrease) in Income Tax Payable |
7,976.00 |
-10,312.00 |
|
Increase (Decrease) in Accrued Expenses |
41,621.00 |
-51,757.00 |
|
Increase (Decrease) in Accrued Pension Liabilities |
-8,111.00 |
5,504.00 |
|
Increase (Decrease) in Other Operating Liabilities |
-4,045.00 |
7,047.00 |
|
Net Cash Provided by (Used in) Operating Activities |
778,312.00 |
467,353.00 |
|
Cash Flows from Investing Activities |
|
|
|
Acquisition of Financial Assets as Fair Value through Profit or Loss |
-410,102.00 |
-350,000.00 |
|
Proceeds from Disposal of Financial Assets as Fair Value through Profit or Loss |
460,818.00 |
380,418.00 |
|
Acquisition of Available-for-sale Financial Assets |
-177,597.00 |
-207,026.00 |
|
Proceeds from Disposal of Available-for-sale Financial Assets |
141,930.00 |
92,129.00 |
|
Acquisition of Financial Assets Carried at Cost |
-16,800.00 |
0.00 |
|
Acquisition of Investments Accounted for by Equity Method |
-32,800.00 |
-117,200.00 |
|
Proceeds from Disposal of Investments Accounted for by Equity Method |
44,458.00 |
107,719.00 |
|
Proceeds from Capital Reduction of Investments Accounted for under Equity Method |
10,410.00 |
0.00 |
|
Purchase of Property, Plant and Equipment |
-416,630.00 |
-639,186.00 |
|
Proceeds from Disposal of Property, Plant and Equipment |
3,944.00 |
2,143.00 |
|
Decrease (Increase) in Other Financial Assets |
-43.00 |
17,066.00 |
|
Decrease (Increase) in Other Assets |
0.00 |
0.00 |
|
Net Cash Provided by (Used in) Investing Activities |
-392,412.00 |
-713,937.00 |
|
Cash Flows from Financing Activities |
|
|
|
Increase (Decrease) in Short-term Loans |
24,525.00 |
-110,458.00 |
|
Proceeds from Long-term Debt |
0.00 |
700,000.00 |
|
Repayment of Long-term Debt |
0.00 |
-240,000.00 |
|
Cash Dividends Paid |
-214,589.00 |
-234,097.00 |
|
Net Cash Provided by (Used in) Financing Activities |
-190,064.00 |
115,445.00 |
|
Net Increase (Decrease) in Cash and Cash Equivalents |
195,836.00 |
-131,139.00 |
|
Cash and Cash Equivalents, Beginning of year |
244,241.00 |
375,380.00 |
|
Cash and Cash Equivalents, End of year |
440,077.00 |
244,241.00 |
|
Supplemental Cash Flow Information |
|
|
|
Interest Paid- Excluding Capitalized Interest |
21,312.00 |
23,544.00 |
|
Income Tax Paid |
49,469.00 |
57,514.00 |
|
Non-cash Investing and Financing Activities |
|
|
|
Capital Increase by Earnings Recapitalization |
214,589.00 |
390,162.00 |
|
Unrealized Valuation Gains or Losses on Financial Instruments |
198,035.00 |
-109,340.00 |
|
Unrealized Gains or Losses on Financial Instruments Recognized due to Equity Changes in Long-term Investments |
574.00 |
-63.00 |
|
Cumulative Translation Adjustments |
-41,531.00 |
95,609.00 |
|
Changes in Equity of Long-term Investment under Equity Method |
-29,624.00 |
47,840.00 |
|
Others |
220,090.00 |
15,728.00 |
|
Investing Activities Affecting Both Cash and Non-cash Items |
|
|
|
Cash Paid for Acquisition of Property, Plant and Equipment |
|
|
|
Increase in Property, Plant and Equipment |
442,702.00 |
624,301.00 |
|
Increase (Decrease) in Payable for Equipment Purchased |
-26,072.00 |
14,885.00 |
|
Cash Paid for Acquisition of Property, Plant and Equipment |
416,630.00 |
639,186.00 |
|
Cash Received from Disposal of Property, Plant and Equipment |
|
|
|
Cash received from sale of Long-term Investment in Stock |
|
|
|
Proceeds from Disposal of Long-term Investments under Equity Method |
44,458.00 |
107,719.00 |
|
Cash received from Disposal of Long-term Investments under Equity Method |
44,458.00 |
107,719.00 |
Note: The subject declined to disclose its financial figures of 2013, we just offered the subject’s financial figures of 2012 and 2011 obtained from public files for references.
Subject declined to disclose its bank details; from other source we cannot obtain the relevant information, either.
Mortgage
|
Case Type: |
Chattel Mortgage |
|
Certificate No.: |
062387 |
|
Debtor Name: |
Everlight Chemical Industrial Corporation |
|
Document Number: |
857170 |
|
Date of Registration: |
1999-6-29 |
|
Date of Alteration: |
-- |
|
Status: |
Paid off |
Lawsuit
Up to date of reporting, no existing or latent litigation of the subject has been found.
|
Name |
Ms. Gan |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.43 |
|
|
1 |
Rs.100.12 |
|
Euro |
1 |
Rs.79.74 |
INFORMATION DETAILS
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.